Abstract: This application provides a data encoding and decoding method and a related device. In the encoding method, side information feature extraction is performed on a first feature map of current data, and quantization processing is performed, to obtain a first quantized feature map. Entropy encoding is performed based on the first quantized feature map, to obtain a first bitstream of the current data. A scaling coefficient is obtained based on the first quantized feature map, scaling processing is performed on a second feature map based on the scaling coefficient, and quantization processing is performed, to obtain a second quantized feature map. Scaling processing is performed on a first probability distribution parameter based on the scaling coefficient, to obtain a second probability distribution parameter, and entropy encoding is performed on the second quantized feature map based on the second probability distribution parameter, to obtain a second bitstream of the current data.

Abstract: A touch substrate, a display apparatus and a display system are provided. By rearranging and distributing transistors in each shift register, the number of transistors in a lateral direction is less than that of transistors in a longitudinal direction. That is a circuit structure of the shift register is designed to extend longitudinally, so that a size of the shift register in the lateral direction can be reduced, a narrow frame design is realized, and seamless splicing is favorably realized in a large-sized display panel.

Abstract: A developing cartridge includes: a cartridge body for accommodating developers; a driving part at a first end in a first direction; a developing roller rotatable about a rotation axis extending along the first direction and positioned at a third end in a second direction; a storage medium for storing information; an electrical contact surface electrically connected to the storage medium and fixed relative to the cartridge body, and a lifting element configured to lift up the cartridge body in the third direction. The electrical contact surface is positioned at the first end in the first direction and is farther away from the developing roller relative to the driving part. The lifting element is farther away from the developing roller in the second direction away from the driving part.

Abstract: This application relates to the field of picture compression technologies, and in particular, to a picture encoding method and apparatus and a picture decoding method and apparatus. The picture decoding method includes: obtaining a side information bitstream of a to-be-decoded picture (1301); and obtaining a picture side information feature based on the side information bitstream (1302), and obtaining a preview picture based on the picture side information feature (1303). The picture side information feature is a second picture feature set obtained by performing, based on a hyperprior encoding neural network, feature extraction on a first picture feature set corresponding to the to-be-decoded picture. Based on the foregoing decoding solution, a decoder side may quickly obtain the preview picture based on the side information bitstream.

Abstract: The disclosure provides at least one compound, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of formula (I), deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing, compositions comprising the same, and methods of making and using the same, including use in treating APOL1 mediated kidney disease.

Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Abstract: The present application discloses a negative electrode, a secondary battery and a device comprising the same. The negative electrode includes: a current collector; a first active material layer close to the current collector, the first active material layer including a first active material; and a second active material layer disposed on a surface of the first active material layer away from the current collector, the second active material layer including a second active material; wherein the first active material and the second active material are independently oval-like particles with through holes and/or blind holes, and the first active material has an average pore size greater than that of the second active material.

Abstract: A battery system, includes: a first output terminal and a second output terminal; a first battery and a second battery, in which, a first electrode of the first battery and a first electrode of the second battery are connected to the first output terminal, a second electrode of the first battery and a second electrode of the second battery are connected to the second output terminal; and a first unidirectional conduction element and a second unidirectional conduction element, in which, one electrode of the first battery is connected to the first output terminal or the second output terminal corresponding to the one electrode of the first battery through the first unidirectional conduction element; and one electrode of the second battery is connected to the first output terminal or the second output terminal corresponding to the one electrode of the second battery through the second unidirectional connection element.

Abstract: The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).

Abstract: Provided herein are compounds having an amide-based backbone that is connected to multiple ring structures, pharmaceutically acceptable salts of the compounds, pharmaceutical compositions thereof, and method of use thereof as selective allosteric inhibitors of EGFR mutants.

Abstract: The present invention provides compounds of Formula I?, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

Abstract: Provided are a battery regulation system and method and an electrical device thereof. The battery regulation system is applied to a vehicle comprising a first motor and a second motor; and the battery regulation system comprises a battery module, a regulation module, and a control module, wherein the regulation module is electrically connected to the battery module and the control module; the battery module comprises a first battery and a second battery, the first battery and the second battery being connected in series, wherein the first battery is used for powering the first motor and the second battery is used for powering the second motor; and the control module is used for controlling the regulation module to regulate the states of charge of the first battery and the second battery when the states of charge of the first battery and the second battery are not consistent.

Abstract: The disclosure provides at least one entity chosen from compounds of Formula (I) pharmaceutically acceptable salts thereof, solvates of any of the foregoing, and deuterated derivatives of any of the foregoing, compositions comprising the same, and methods of using the same, including use in treating APOL1 mediated kidney disease.

Abstract: The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).

Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Abstract: The present application provides a mounting base, a battery and a power consuming device, which relate to the technical field of batteries. The mounting base may be configured to be connected to an end plate and an output electrode, and an insulating structure may be provided on one side of the end plate and configured to insulate the end plate from a battery cell. The mounting base may include a main body provided with a flow guiding groove on the side facing the insulating structure. The flow guiding groove may be configured to prevent an electrical connection between the output electrode and the end plate by means of a liquid between the main body and the insulating structure.

Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Abstract: Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Abstract: The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

Abstract: The disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).